Finally, to further determine the role of IPMK and the AMPK/ULK1 pathway in ebastine-mediated antitumor activity in vivo, we examined expression of IPMK and the AMPK/ULK1 pathway in subcutaneous tumor tissues. The gene discussed is IPMK; the disease is neoplasm.